• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.

作者信息

Krause Philip R, Fleming Thomas R, Longini Ira M, Peto Richard, Beral Valerie, Bhargava Balram, Cravioto Alejandro, Cramer Jakob P, Ellenberg Susan S, Figueroa J Peter, Halloran Elizabeth, Henao-Restrepo Ana M, Ryan Michael J, Levine Myron M, Nason Martha, Nohynek Hanna M, Plotkin Stanley, Rees Helen, Singh Jerome A, Swaminathan Soumya

机构信息

The affiliations of the members of the WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation are the Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring (P.R.K.), the School of Medicine, University of Maryland (M.M.L.), and Johns Hopkins University (S.P.), Baltimore, and the National Institute of Allergy and Infectious Diseases, Bethesda (M.N.) - all in Maryland; the Department of Biostatistics (T.R.F.), Fred Hutchinson Cancer Research Center (T.R.F., E.H.), University of Washington, Seattle; the Department of Biostatistics, University of Florida, Gainesville (I.M.L.); the Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom (R.P., V.B.); the Indian Council of Medical Research, New Delhi (B.B.); the Faculty of Medicine of the Universidad Nacional Autónoma de México, Mexico City (A.C.); the Coalition for Epidemic Preparedness Innovations, London (J.P.C.); the University of Pennsylvania, Philadelphia (S.S.E., S.P.); the University of the West Indies, Kingston, Jamaica (J.P.F.); the World Health Organization, Geneva (A.M.H.-R., M.J.R., S.S.); the Department of Health Security, Finnish Institute for Health and Welfare, Helsinki (H.M.N.);and the Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg (H.R.), and the Centre for the AIDS Programme of Research in South Africa, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban (J.S.) - both in South Africa.

出版信息

N Engl J Med. 2021 Jan 14;384(2):e2. doi: 10.1056/NEJMp2033538. Epub 2020 Dec 2.

DOI:10.1056/NEJMp2033538
PMID:33264543
Abstract
摘要

相似文献

1
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.新冠疫苗的安慰剂对照试验——我们为何仍需要它们。
N Engl J Med. 2021 Jan 14;384(2):e2. doi: 10.1056/NEJMp2033538. Epub 2020 Dec 2.
2
Placebo-controlled trials with COVID-19 vaccines: participants first.COVID-19疫苗的安慰剂对照试验:参与者至上。
J Clin Epidemiol. 2021 Oct;138:211-212. doi: 10.1016/j.jclinepi.2021.07.004. Epub 2021 Jul 13.
3
COVID-19 vaccine trials: The potential for "hybrid" analyses.COVID-19 疫苗试验:“混合”分析的可能性。
Clin Trials. 2021 Aug;18(4):391-397. doi: 10.1177/17407745211018613. Epub 2021 May 27.
4
Placebo control group in COVID-19 vaccine trials: context and timing matters.新冠疫苗试验中的安慰剂对照组:背景和时机很重要。
Eur J Clin Pharmacol. 2022 Mar;78(3):523-526. doi: 10.1007/s00228-021-03259-x. Epub 2021 Nov 27.
5
Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical?当前高收入国家的新冠疫苗试验:安慰剂对照试验是否符合伦理道德?
Clin Microbiol Infect. 2021 Nov;27(11):1565-1567. doi: 10.1016/j.cmi.2021.08.005. Epub 2021 Aug 8.
6
Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.继续批准在低收入和中等收入国家进行安慰剂对照的新冠疫苗试验的基本原理。
Lancet. 2021 Mar 6;397(10277):878. doi: 10.1016/S0140-6736(21)00357-3. Epub 2021 Feb 19.
7
Trial participants' rights after authorisation of COVID-19 vaccines.新冠疫苗获批后试验参与者的权利。
Lancet Respir Med. 2021 Apr;9(4):e30-e31. doi: 10.1016/S2213-2600(21)00044-8. Epub 2021 Jan 18.
8
COVID-19 vaccine trials: The use of active controls and non-inferiority studies.COVID-19 疫苗试验:活性对照和非劣效性研究的应用。
Clin Trials. 2021 Jun;18(3):335-342. doi: 10.1177/1740774520988244. Epub 2021 Feb 3.
9
Testing vaccines in the time of Covid: The changing landscape.新冠疫情期间的疫苗测试:不断变化的形势。
Indian J Med Ethics. 2021 Apr-Jun;VI(2):1-4. doi: 10.20529/IJME.2021.018.
10
Vaccines for preventing infections in adults with solid tumours.用于预防实体瘤成年患者感染的疫苗。
Cochrane Database Syst Rev. 2025 Apr 16;4(4):CD015551. doi: 10.1002/14651858.CD015551.pub2.

引用本文的文献

1
A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events.关于妥善实施《国际人用药品注册技术协调会E9(R1)增编:处理并发事件的策略》的观点
Stat Med. 2025 May;44(10-12):e70104. doi: 10.1002/sim.70104.
2
The COVID-19 Vaccine in Clinical Trials: Where Are We Now?新冠病毒疫苗的临床试验:我们目前进展到哪一步了?
Infect Dis Immun. 2021 Apr 20;1(1):43-51. doi: 10.1097/ID9.0000000000000003. eCollection 2021 Apr.
3
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign.
新冠病毒mRNA疫苗:注册试验和全球疫苗接种运动的经验教训
Cureus. 2024 Jan 24;16(1):e52876. doi: 10.7759/cureus.52876. eCollection 2024 Jan.
4
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.含 AS03 佐剂的二价(D614G+B.1.351)SARS-CoV-2 重组蛋白疫苗在成年人中的效力:一项 3 期、平行、随机、修改的双盲、安慰剂对照试验。
Lancet Respir Med. 2023 Nov;11(11):975-990. doi: 10.1016/S2213-2600(23)00263-1. Epub 2023 Sep 13.
5
'Spikeopathy': COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA.“刺突蛋白病变”:新冠病毒刺突蛋白具有致病性,病毒和疫苗mRNA中的刺突蛋白均如此。
Biomedicines. 2023 Aug 17;11(8):2287. doi: 10.3390/biomedicines11082287.
6
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine.AZD1222(ChAdOx1 nCoV-19)疫苗3期试验的免疫相关分析。
NPJ Vaccines. 2023 Mar 11;8(1):36. doi: 10.1038/s41541-023-00630-0.
7
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2.回顾性观察研究估计疫苗对 SARS-CoV-2 二次攻击率的影响。
Am J Epidemiol. 2023 Jun 2;192(6):1016-1028. doi: 10.1093/aje/kwad046.
8
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.预防 19 型 COVID-19 疫苗疗效临床试验的免疫相关性分析。
Nat Commun. 2023 Jan 19;14(1):331. doi: 10.1038/s41467-022-35768-3.
9
Efficacy and safety of COVID-19 vaccines.新型冠状病毒疫苗的有效性和安全性。
Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.
10
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.ENSEMBLE COVID-19疫苗效力临床试验中单次Ad26.COV2.S剂量的免疫相关分析
medRxiv. 2022 Apr 12:2022.04.06.22272763. doi: 10.1101/2022.04.06.22272763.